Financial reports
Current reports
6-K
Emtn Programme: Publication of Base Prospectus
7 May 24
6-K
Haleon 2024 Q1 Trading Statement
1 May 24
6-K
Directorate Change
1 May 24
6-K
Current report (foreign)
1 May 24
6-K
Appointment of Dawn Allen As CFO
24 Apr 24
6-K
Notice of Annual General Meeting (Agm)
12 Apr 24
6-K
Director/pdmr Shareholding
3 Apr 24
6-K
Total Voting Rights and Capital
2 Apr 24
6-K
Holding(s) In Company
22 Mar 24
6-K
Current report (foreign)
21 Mar 24
Registration and prospectus
25-NSE
Exchange delisting
25 Mar 24
424B1
Prospectus with pricing info
19 Mar 24
424B1
Prospectus with pricing info
18 Mar 24
F-3ASR
Automatic shelf registration (foreign)
3 Jul 23
424B3
Prospectus supplement
3 May 23
424B3
Prospectus supplement
20 Apr 23
25-NSE
Exchange delisting
24 Mar 23
424B3
Prospectus supplement
24 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
424B3
Prospectus supplement
2 Mar 23
Proxies
No filings
Other
SD
Conflict minerals disclosure
26 May 23
EFFECT
Notice of effectiveness
24 Mar 23
CT ORDER
Confidential treatment order
19 Dec 22
CERT
Certification of approval for exchange listing
3 Nov 22
EFFECT
Notice of effectiveness
28 Oct 22
CORRESP
Correspondence with SEC
25 Oct 22
CORRESP
Correspondence with SEC
24 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22
UPLOAD
Letter from SEC
17 Oct 22
UPLOAD
Letter from SEC
12 Oct 22
Ownership
SC 13D/A
PFIZER INC
22 Mar 24
SC 13D/A
PFIZER INC
19 Mar 24
SC 13D/A
GSK plc
19 Jan 24
SC 13D/A
PFIZER INC
19 Jan 24
144
Notice of proposed sale of securities
29 Dec 23
144
Notice of proposed sale of securities
5 Dec 23
144
Notice of proposed sale of securities
3 Nov 23
SC 13D/A
PFIZER INC
10 Oct 23
SC 13D/A
GSK plc
10 Oct 23
SC 13D/A
GSK plc
11 Sep 23